NEWS
The information contained in each news post on this page was factually accurate on the date it was issued and posted.
Sutro Biopharma Announces Company KOL Virtual Event to Provide Interim Dose Expansion Data for Antibody-Drug Conjugate Program STRO-002 for Treatment of Advanced Ovarian Cancer
- Dr. Naumann and Sutro management to discuss interim data on the STRO-002 Phase 1 dose-expansion cohort at Company event scheduled for Wednesday, Jan. 5, 2022 at 5 pm ET, or 2 pm PT SOUTH SAN FRANCISCO, Calif., Dec. 27, 2021 – Sutro Biopharma, Inc. (“Sutro”),...
Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for STRO-002 in Greater China
- Tasly obtains exclusive development and commercialization rights for STRO-002 for Greater China - - License includes a $40 million upfront payment to Sutro, and potentially up to $345 million in development and commercial milestone payments - - Partnership builds on...
Fred Hutchinson Cancer Research Center, in Partnership with Sutro Biopharma, to Present at ASH 2021
– Nonclinical data for STRO-002 and STRO-001 are shared in two oral presentations at the 63rd American Society of Hematology Annual Meeting SOUTH SAN FRANCISCO, Calif, Dec. 13, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development...
4th Annual Evercore ISI HeathCONx Conference – Presentation
Webcast, Nov 30, 2021 at 10:05am EST Download Presentation, Click Here
Piper Sandler 33rd Annual Healthcare Conference – Presentation
Webcast, Nov 22, 2021 at 10:00am EST Download Presentation, Click here
Sutro Biopharma to Participate in Two Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 22, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and...
Jefferies London Healthcare Conference – Presentation
Webcast: Nov 18, 2021 at 3:00am EST Download: Click Here
Sutro Biopharma Announces Appointment of Heidi Hunter to Board of Directors
- Heidi Hunter, accomplished healthcare leader and President of Cardinal Health Specialty Solutions, to bring additional global biopharma strategic and operational expertise to Sutro's Board - SOUTH SAN FRANCISCO, Nov. 17,2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a...
Stifel 2021 Virtual Healthcare Conference – Presentation
Webcast: Nov 15, 2021 at 1:20pm EST Download: Click Here
Credit Suisse 30th Annual Healthcare Conference – Presentation
Webcast, Nov 10, 2021 at 4:20pm EST Download Presentation, Click Here
